Dilara Ogunc

Dilara Ogunc

Auto-generated profile, based on publicly available information

Dilara Ogunc

Department of Medical Microbiology, Faculty of Medicine, Akdeniz University, Antalya 07058, Turkey

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
PDF file
MNMarcio Nucci
Marcio Nucci
KMK.A. Marr
K.A. Marr
MVM.J.G.T. Vehreschild
M.J.G.T. Vehreschild
CSC.A. de Souza
C.A. de Souza
EVE. Velasco
E. Velasco
EAE. Anaissie
E. Anaissie
Invasive fusariosis (IF) is a leading mycosis affecting immunocompromised patients [1 x 1 Nucci, M and Anaissie, E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007; 20: 695–704 Crossref | PubMed | Scopus (454) | Google Scholar See all References ]. The disease is usually invasive and disseminated, affecting mostly neutropenic patients with acute leukaemia [2 x 2 Nucci, M, Anaissie, EJ, Queiroz-Telles, F et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer. 2003; 98: 315–319 Crossref | PubMed | Scopus (169) | Google Scholar See all References ] or patients with severe T-cell immunodeficiency, especially haematopoietic cell transplant recipients receiving corticosteroids for the treatment of severe graft-versus-host disease (GVHD) [3 x 3 Nucci, M, Marr, KA, Queiroz-Telles, F et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2004; 38: 1237–1242 Crossref | PubMed | Scopus (208) | Google Scholar See all References ]. Most infections in humans are caused by Fusarium solani species complex and Fusarium oxysporum species complex [1 x 1 Nucci, M and Anaissie, E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007; 20: 695–704 Crossref | PubMed | Scopus (454) | Google Scholar See all References ].

18 August 2009 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
VUVedat Uygun
Vedat Uygun
GKGulsun Tezcan Karasu
Gulsun Tezcan Karasu
DODilara Ogunc
Dilara Ogunc
AYAkif Yesilipek
Akif Yesilipek
VHVolkan Hazar
Volkan Hazar

7 January 2016 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
AÇAslı ÇAKAR
Aslı ÇAKAR
YAYakut Akyön
Yakut Akyön
DGDeniz Gür
Deniz Gür
OKOnur Karatuna
Onur Karatuna
DÖDilara Öğünç
Dilara Öğünç
MPMehmet Parlak
Mehmet Parlak
Carbapenems are the choice of treatment in infections caused by multidrug resistant Enterobacteriaceae. In recent years carbapenem-resistant Enterobacteriaceae isolates due to carbapenemases have been increasingly reported worldwide. Multicenter studies on carbapenemases are scarce in Turkey. The aim of this study was to determine the distribution of carbapenemases from different parts of Turkey as a part of the European Survey of Carbapenemase Producing Enterobacteriaceae (EuSCAPE) project. Beginning in November 2013, carbapenem-resistant isolates resistant to at least one of the agents, namely imipenem, meropenem, and ertapenem were sent to the coordinating center. Minimum inhibitory concentrations for these carbapenems were determined by microdilution tests following EUCAST guidelines. Production of carbapenemase was confirmed by combination disk synergy tests. Types of carbapenemases were investigated using specific primers for VIM, IMP; NDM, KPC and OXA-48 genes by multiplex polymerase chain reaction. In a six month period, 155 suspected carbapenemase-positive isolates were sent to the coordinating center of which 21 (13.5%) were E.coli and 134 (86.5%) were K.pneumoniae. Nineteen (90.5%) strains among E.coli and 124 (92.5%) strains among K.pneumoniae were shown to harbour at least one carbapenemase gene by molecular tests, with a total of 92.3% (143/155). Carbapenemases were determined as a single enzyme in 136 strains (OXA-48: 84.6%; NDM: 6.3%; VIM: 2.8%; IMP: 1.4%) and as a combination in seven isolates (OXA-48 + NDM: 2.1%; OXA-48 + VIM: 2.1%; VIM + NDM: 0.7%). KPC was not detected in any of the isolates. According to the microdilution test results, resistance to imipenem, meropenem and ertapenem in OXA-48 isolates were 59.5%, 52.9% and 100%, respectively. The combination disk synergy test was 100% compatible with the molecular test results. As most of the OXA-48 producing isolates were susceptible to meropenem but all were resistant to ertapenem, ertapenem seems to be the most sensitive agent in screening carbapenemases in areas where OXA-48 is prevalent and phenotypic combination tests can be useful in centers where molecular tests are not available.

1 July 2012 in Medical Mycology
Verified
Journal Article
Open access
PDF file
BOBetil Ozhak-Baysan
Betil Ozhak-Baysan
DODilara Ogunc
Dilara Ogunc
DCDilek Colak
Dilek Colak
GOGozde Ongut
Gozde Ongut
LDLevent Donmez
Levent Donmez
FGFiliz Gunseren
Filiz Gunseren
The aim of the study was to investigate the distribution of Candida species isolated from urine specimens of hospitalized patients in Akdeniz Univers

25 September 2019 in Mycoses
Verified
Journal Article
Closed access
PDF file
MHMohammad T. Hedayati
Mohammad T. Hedayati
MTMojtaba Taghizadeh‐Armaki
Mojtaba Taghizadeh‐Armaki
Hossein ZarrinfarHossein Zarrinfar
Hossein Zarrinfar
AHAkbar Hoseinnejad
Akbar Hoseinnejad
SASaham Ansari
Saham Ansari
SSSeyedmojtaba Seyedmousavi
Seyedmojtaba Seyedmousavi

1 January 2009 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
GTGulsum Tezcan
Gulsum Tezcan
BOBetil Ozhak-Baysan
Betil Ozhak-Baysan
Ana Alastruey-IzquierdoAna Alastruey-Izquierdo
Ana Alastruey-Izquierdo
DODilara Ogunc
Dilara Ogunc
GOGozde Ongut
Gozde Ongut
JRJuan Luis Rodriguez-Tudela
Juan Luis Rodriguez-Tudela
Fusarium species are saprophytic molds which cause disseminated or localized infections in humans. Disseminated Fusarium infection can cause significant morbidity and mortality in immunocompromised patients. We present a case of disseminated fusariosis caused by Fusarium verticillioides in a patient with acute lymphoblastic leukemia and successfully treated using both liposomal amphotericin B and voriconazole.